Psychosis in Parkinson's disease: case studies

Brian C Salter; Karen E Anderson; William J Weiner

doi:10.1016/j.ncl.2006.01.003

Psychosis in Parkinson's disease: case studies

Neurol Clin. 2006 May;24(2):363-9. doi: 10.1016/j.ncl.2006.01.003.

Authors

Brian C Salter¹, Karen E Anderson, William J Weiner

Affiliation

¹ Department of Neurology, University of Maryland School of Medicine, Baltimore, MD 21202, USA.

PMID: 16684637
DOI: 10.1016/j.ncl.2006.01.003

Abstract

Psychosis is common in patients who have PD and leads to significant disability. Patients often can be managed with non-pharmacologic interventions or with decreasing doses of anti-parkinsonism medications. If these interventions are insufficient, then atypical antipsychotics should be considered. Clozapine is used in more refractory cases and requires stringent monitoring for agranulocytosis.

Publication types

Case Reports
Review

MeSH terms

Aged
Antiparkinson Agents / therapeutic use
Antipsychotic Agents / therapeutic use
Female
Humans
Levodopa / therapeutic use
Male
Middle Aged
Parkinson Disease / drug therapy
Parkinson Disease / psychology*
Psychotic Disorders / diagnosis
Psychotic Disorders / drug therapy
Psychotic Disorders / etiology*
Severity of Illness Index

Substances

Antiparkinson Agents
Antipsychotic Agents
Levodopa